Abstract:Background: The epidemiology of cannabinoid-related cancerogenesis has not been studied with cutting edge epidemiological techniques. Building on earlier bivariate papers in this series we aimed to conduct pathfinding studies to address this gap in two tumours of the reproductive tract, prostate and ovarian cancer. Methods: Age-standardized cancer incidence data for 28 tumour types (including "All (non-skin) Cancer") was sourced from Centres for Disease Control and National Cancer Institute using SEER*Stat software across US states 2001-2017. Drug exposure was sourced from the nationally representative household survey National Survey of Drug Use and Health conducted annually by the Substance Abuse and Mental Health Services Administration 2003-2017 with response rate 74.1%. Federal seizure data provided cannabinoid concentration data. US Census Bureau provided income and ethnicity data. Inverse probability weighted mixed effects, robust and panel regression together with geospatiotemporal regression analyses were conducted in R. E-Values were also calculated. Results: 19,877 age-standardized cancer rates were returned. Based on these rates and state populations this equated to 51,623,922 cancer cases over an aggregated population 2003-2017 of 124,896,418,350. Inverse probability weighted regressions for prostate and ovarian cancers confirmed causal associations robust to adjustment. Cannabidiol alone was significantly associated with prostate cancer (β-estimate = 1.61, (95%C.I. 0.99, 2.23), P = 3.75 × 10- 7). In a fully adjusted geospatiotemporal model at one spatial and two temporal years lags cannabidiol was significantly independently associated with prostate cancer (β-estimate = 2.08, (1.19, 2.98), P = 5.20 × 10- 6). Cannabidiol alone was positively associated with ovarian cancer incidence in a geospatiotemporal model (β-estimate = 0.36, (0.30, 0.42), P < 2.20 × 10- 16). The cigarette: THC: cannabidiol interaction was significant in a fully adjusted geospatiotemporal model at six years of temporal lag (β-estimate = 1.93, (1.07, 2.78), P = 9.96 × 10- 6). Minimal modelled polynomial E-Values for prostate and ovarian cancer ranged up to 5.59 × 1059 and 1.92 × 10125. Geotemporospatial modelling of these tumours showed that the cannabidiol-carcinogenesis relationship was supra-linear and highly sigmoidal (P = 1.25 × 10- 45 and 12.82 × 10- 52 for linear v. polynomial models). Conclusion: Cannabinoids including THC and cannabidiol are therefore important community carcinogens additive to the effects of tobacco and greatly exceeding those of alcohol. Reproductive tract carcinogenesis necessarily implies genotoxicity and epigenotoxicity of the germ line with transgenerational potential. Pseudoexponential and causal dose-response power functions are demonstrated.

Causal Relationship Between Cannabis Use and Cancer: a Genetically Informed Perspective

Conversion by rat brain preparation of lignoceric acid to ceramides and cerebrosides containing both alpha-hydroxy and nonhydroxy fatty acids. Effects of compounds which affect sphingolipid metabolism.

Causal Relationship Between Prostatic Diseases and Prostate Cancer: a Mendelian Randomization Study

The impact of cannabis use on erectile dysfunction and sex hormones: a Mendelian randomization analysis

Exploring the Cross-Cancer Effect of Smoking and Its Fingerprints in Blood DNA Methylation on Multiple Cancers: A Mendelian Randomization Study

Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study

Association Between Cannabis Use and Brain Structures: A Mendelian Randomization Study

Cancers and COVID-19 Risk: A Mendelian Randomization Study

Association between common chronic pulmonary diseases and lung cancer: Mendelian randomization analysis

Association of Cannabis Use Disorder with Cardiovascular Diseases: A Two-Sample Mendelian Randomization Study

The causal relationship between smoking, alcohol consumption, and renal clear cell carcinoma: a Mendelian randomization study

Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003–2017

Genetic prediction of the causal relationship between schizophrenia and tumors: a Mendelian randomized study

Genetic Support of a Causal Relationship Between Cannabis Use and Educational Attainment: a Two-Sample Mendelian Randomization Study of European Ancestry.

Causality of genetically determined metabolites on susceptibility to prevalent urological cancers: a two-sample Mendelian randomization study and meta-analysis

Revealing a causal relationship between gut microbiota and lung cancer: a Mendelian randomization study

Association between 19 medication use and risk of common cancers: A cross-sectional and Mendelian randomisation study

Causal relationship between anti-inflammatory drugs and cancer: a pan-cancer study with Mendelian randomization

Cannabis use is associated with patient and clinical factors in a population-based sample of colorectal cancer survivors

Genetic Effect of Metformin Use on Risk of Cancers: Evidence from Mendelian Randomization Analysis